Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
(Thumbs up)
And my series of “???“s were “thumbs up” emojis. Not question marks.
Lots of helpful DD that guy does. Perhaps some is not relevant (don’t 100% know yet) but will be exciting to look back a year or two from now and realize what was (or not) right in front of us. And at what (potentially crazy cheap) price per share.
????????????????
Scratch that. Not “this last year” it was only 4 months ago! ????
Any DoD presentation conf feedback?
It was yesterday and today
Any merger news? This thing was $15-18 just last year. $.42 and $1-200K market cap makes no sense.
Either this is going to zero or the buying opportunity of a lifetime.
It's weird.
Still believe there's about 100-150% upside in FLCX until parity around $9-10. QREE shareholder letter mentioned $30M market cap combined entity post merger so that's where the logic originates.
2x is pretty darn good regardless.
GL
We’ve been invested in QEGY now QREE for over six years. Well aware of what’s going on with the company. And Dennis. And Bill.
Hint. You’re neglecting the 1:150 reverse split that happened a few months ago.
GL to you
Likely around $9. Then it and QREE merge. Combined outstanding shares gets new QREE merged entity to about $30M market cap.
They up-list and start sharing their discussions about pre-orders and interactions with the DOE and Seimens, and or other interested parties. Get some good PRs out there and expand their investor base.
Buyers come in.
GLTA longs
QREE currently has a market cap of about $3M.
https://finance.yahoo.com/quote/QREE
Don't need to convince us. We are fully invested and believers in both the INKmune NK cell therapy for certain cancers as well as XPro for AD and possibly others neuro inflammation sensitive diseases, including Parkinson’s.
Two robust programs and each have multi-billion value potential based on TAM
Exciting times.
GLTA longs
My guess is this and FLCX merge at $9. Total share count outstanding becomes roughly 3 million.Yields resulting market cap of $27M
Total guess.
Dennis already said they had $18M in pre-sales. So $27M mC not frothy. But not sure how much we can believe from him. Not good track record for honesty.
GLTA
Nope
BS. The group’s $7M in annual revenue represents about one tenth of one per event of the company’s $5,760M [$5.76 BILLION] annual revenue.
“Those of us who knew them will miss the Marchettis, but good riddance to Mr. Porter. Grade A, first-round ballot Hall of Fame AAA-hole.” No loss there.
Do you find it strange that the Earth Engine is put on public display for the very first time at POWERGEN to “over 1,000” attendees and QEGY stock does nothing and FLCX tanks nearly 50% during and after?
One large order should do it. These single orders are the trickle that becomes a stream that becomes a river.
Read the letter to shareholders. Explains the benefits quite clearly.
What does PRCX have to do with anything?
Well. That was interesting
Well. $FLCX is down 12%+ today so did exhibitors not like what they saw?
*Your
You’re opinion this goes up 40% in 3 days why?
Good to see Quantum Energy has a big corner booth. #2852. Typically means they have large displays and large booth good for mingling in an open area versus a crappy small booth for “smaller” vendors. It’s what we’ve found at such type conferences.
If someone here goes please take pics to post or report back.
Thanks
Exhibitor or speaker or both? Press release?
Public companies have an obligation to their shareholders to update them on what they’re doing. Is this not a public company?
Quiet for an entire year. Is this company doing anything?
Shorts? There’s no short play here. It’s likely frustrated shareholders post split getting out. It’s literally a trickle of volume. This is just games at this point until the company actual shows progress towards a revenue generating anything.
It’s “trading” at half its cash on hand value. Silly.
Part of it. My guess is they will raise cash too. With only 330K shares outstanding it would seem possible they increase to 1M shares outstanding and raise $12M. Gives them $20M runway with only $18M market cap. So at $18/share still trading below cash value.
With bolstered balance sheet and share price safely above minimums they can up-list, giving shares opportunity to better trade and retail (eventually) institutional investors step in.
Once they get their affairs in order they can start revealing (news) about what company has been doing.
Just a guess
Yep. Just waiting on those promised deals by Glenn.
“Should have $20M market cap” based on what?
For our sake hope this is not the “material news”
So now the company is only worth $12.5M. How does this help us again?
And will the market really think it’s worth more than $12.5M without material news?
Guess we shall see…
????and will mark this post ????
And when do you predict we get some news about company progress in a meaningful way? I mean what have they been doing other than restructuring and having a board member resign and updating a website?
Is it?
What does this have to do with Quantum?
XPro news also impressive. Data very.
“The data from this Phase I trial show that XPro decreases biomarkers of neuroinflammation and nerve cell death while improving biomarkers of neurorepair in patients with AD,” stated RJ Tesi, M.D., CEO of INmune Bio
INKmune news was impressive. Albeit one patient dosed additional eight (8) in line. No toxicity. Ovarian cancer on deck.
https://finance.yahoo.com/news/inmune-bio-inc-announces-biomarker-200000970.html
Won’t need to.
“William Westbrook, CFO has also confirmed that the Company has now met all of its filing requirements, and has applied for listing on the OTC.QB as a fully reporting company. "The Company goal is to greatly increase transparency, that will allow for future forecasting, and access to debt for growth".